Risk factor
Negligible price volatility
Profitability factor
Solid dividends
About
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies;...
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV
Target Price
The average target price of QGEN is 58 and suggests 42% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell